Print Mission

PharmaQbD.comPharmaQbD advances a smarter approach to drug development—a more scientific, efficient and less "hit-and-miss" approach. It does this via peer-to-peer exchange of best practices, as well as solutions-oriented, actionable information and ideas to improve the drug development process. There is an urgent need for "best practices" for implementing Quality by Design (QbD) programs and thinking within the drug industry. Currently, as the pace of new drug introductions slows and some established "blockbusters" are found to have serious safety issues, it can take 10-12 years and $1 billion to develop a new drug. Drug makers need to optimize quality and safety, as well as "manufacturability" from the earliest stages of any drug's development and to improve speed to market. This critical industry movement is being advanced by FDA, EMEA and other global regulatory agencies, and is a key part of the ICH's (International Council for Harmonization) Q8, 9 and 10.

Led by Experts—PharmaQbD Editorial Advisory Board

PharmaQbD is honored to have the expertise and experience of numerous industry experts serving on the PharmaQbD Editorial Advisory Board: Audience by Title